BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190227
DTEND;VALUE=DATE:20190303
DTSTAMP:20181225T201437Z
CREATED:20181225T201345Z
LAST-MODIFIED:20181225T201437Z
UID:20800-1551225600-1551571199@globalbiodefense.com
SUMMARY:Advances in Genome Biology and Technology (AGBT)
DESCRIPTION:The Advances in Genome Biology and Technology (AGBT) General Meeting will be held Feb 27 – Mar 2\, 2019 on Marco Island\, Florida. \nAGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies\, experimental and analytical approaches for genomic studies\, and their myriad applications. \nHighlighted presentation topics include: \n\nHeterochromatin and genome evolution\nHistorical pathogen population genomics using selective genome enrichment to identify non-classical drug resistance mechanisms\nIdentity inference of genomic data using long-range familial searches\nTranscript expression-aware annotation increases power for rare variant discovery in Mendelian and complex disease\nCharacterization of splicing diversity and gene fusions through Nanopore sequencing\nSingle cell-RNA-seq identifies a unique microglia type associate with Alzheimer’s disease\nSpatial mapping of host-microbiome interactions in the gut\nAssembly of long error-prone reads using repeat graphs\nIsoform sequencing in tissues\, cell types and thousands of cells\nFrom here to Mars: How the Twins Study and the year-long ISS mission have moved us closer to the red planet\nCell atlases as road maps to human disease\nA rigorous study of the need for Sanger confirmation in clinical genetic testing\n\nPlease visit the AGBT 2019 website for more information.
URL:https://globalbiodefense.com/event/advances-in-genome-biology-and-technology-agbt/
LOCATION:JW Marriott Marco Island Beach Resort\, 400 S Collier Blvd\, Marco Island\, FL\, 34145\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/12/agbt-2019-genome-biology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190304
DTEND;VALUE=DATE:20190308
DTSTAMP:20190429T044259Z
CREATED:20190210T182051Z
LAST-MODIFIED:20190429T044259Z
UID:19288-1551657600-1552003199@globalbiodefense.com
SUMMARY:CROI 2019 - Conference on Retroviruses and Opportunistic Infection
DESCRIPTION:The 2019 Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 4 to March 7\, 2019 in Seattle\, Washington. \nThis well-respected conference brings together top basic\, translational\, and clinical researchers from around the world to share the latest studies\, important developments\, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. \nAn extensive speaker agenda and poster sessions will cover topics in scientific areas of: \n\nPathogenesis: Human Studies and Animal Models\nHIV-Associated Tumor Viruses\nHost Immune Responses to Infection\, Vaccines\, and Immunotherapy\nHIV Reservoirs\, Latency\, and All Curative Strategies Including Therapeutic Vaccines\nand Gene Therapy\nNeuropathogenesis and Neurologic Complications\nClinical Pharmacology\nAntiretroviral Therapy: Pre-Clinical Data\, Randomized Trials\, Efficacy and Effectiveness Studies\nHIV Drug Resistance\nHIV Diagnostics\nHepatitis Viruses and Liver Complications\nAIDS-Related Malignancies\nCardiovascular Complications of HIV Infection and Antiretroviral Therapy\nTuberculosis and Other Opportunistic Infections\nMaternal and Fetal HIV\nEpidemiology\nPrevention Interventions\nContraception\, Sexually Transmitted Infections\, and Reproductive Health\nImplementation and Scale-Up of Treatment and Care\nPopulation and Cost Modeling\n\nPlease visit the Conference on Retroviruses and Opportunistic Infections (CROI) website for more information.
URL:https://globalbiodefense.com/event/croi-2019-conference-on-retroviruses-and-opportunistic-infection/
LOCATION:Washington State Convention Center\, 800 Convention Pl\, Seattle\, WA\, 98101\, United States
CATEGORIES:Conference,Continuing Education
ORGANIZER;CN="International Antiviral Society-USA":MAILTO:info@iasusa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190314
DTSTAMP:20220906T195454Z
CREATED:20190208T212321Z
LAST-MODIFIED:20220906T195454Z
UID:23475-1552348800-1552521599@globalbiodefense.com
SUMMARY:Long-Term Health Monitoring following Nuclear & Radiological Emergencies
DESCRIPTION:The National Academies’ Nuclear and Radiation Studies Board (NRSB) will host “Challenges in Initiating and Conducting Long-Term Health Monitoring of Populations following Nuclear and Radiological Emergencies in the United States: A Workshop” on 12-13 March 2019 in Washington\, D.C. \nWorkshop participants will discuss the following topics: \n\nEnvironmental Consequences of Radioactive Material following a Nuclear or Radiological Incident\nThe need to Prepare for Population Monitoring\nRadiation Dose Reconstruction\nBiodosimetry Tools for Long-Term Health Monitoring\nFollow-up of the Atomic Bombing Survivors\nCommunicating Health Monitoring Following the Salisbury Nerve Agent Attack\nThe Chernobyl Registry\nDosimetry During the Radiological Accident in Goiânia\nThe Fukushima Registry\nRadiation Screening/Decontamination\nMedical Management of Radiation Incidents\nLong-Term Strategies for Thyroid Health Monitoring after Nuclear Accidents\nLessons Learned from Setting up Population Monitoring Registries\nThe Las Vegas Mass Shooting\nOperational Considerations for Setting up and Maintaining a Radiation Registry\n\nAttend in-person or via webcast. Please visit the event registration page for more information.
URL:https://globalbiodefense.com/event/long-term-health-monitoring-following-nuclear-radiological-emergencies/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/nuclear-radiation-studies-board-12mar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190315
DTSTAMP:20190429T044226Z
CREATED:20190223T193806Z
LAST-MODIFIED:20190429T044226Z
UID:23754-1552435200-1552607999@globalbiodefense.com
SUMMARY:NIAID Research Career K-Program Development Workshop
DESCRIPTION:The National Institute of Allergy and Infectious Diseases (NIAID) will host a Research Career “K” Development Workshop 13-14 March 2019 in Rockville\, Maryland. \nThe event is for currently active and new (typically those in year 1 or year 2 of their K award by the end of fiscal year 2018) awardees for the following K programs: \n\nMentored Research Scientist Development Award (K01)\nMentored Clinical Scientist Research Career Development Award (K08)\nNIAID Career Transition Award (K22)\nMentored Patient-Oriented Research Career Development Award (K23)\nMentored Quantitative Research Development Award (K25)\nNIH Pathway to Independence Award (Parent K99/R00)\n\nThe workshop will provide effective ways to transition to research independence (e.g.\, R01 award); the primary goal of the K programs. \nThe workshop will be held on Wednesday\, March 13\, 2019 thru Thursday\, March 14\, 2019 at NIAID\, located at 5601 Fishers Lane in Rockville\, Maryland 20892. \nThe purpose of this workshop is to allow for the exchange of information regarding NIH biomedical research opportunities and professional skills development. It will also provide an opportunity for K awardees to network and interact with their peers and NIAID/NIH staff. Interested K awardees may present their research findings during a poster session. \nThe workshop is free but space may be limited. Please register here.
URL:https://globalbiodefense.com/event/niaid-research-career-k-program-development-workshop/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/niaid-k-researcher-career-development.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20190307T225112Z
CREATED:20181223T215408Z
LAST-MODIFIED:20190307T225112Z
UID:20616-1552867200-1553039999@globalbiodefense.com
SUMMARY:Superbugs & Superdrugs 2019
DESCRIPTION:SMi Group’s Annual Superbugs & Superdrugs conference will take place 18-19 March\, 2019 in London\, UK. \nThis year’s event will gather leaders from pharmaceutical companies\, academia and the wider scientific community together with regulatory agencies and public-private partnerships\, to discuss the growing threat of antibiotic resistance. \nHighlighted session topics and focus areas include: \n\nDevelopment of a pipeline of lysins for infections caused by multidrug-resistant gram-negative bacteria\nAnti-infective research: funding\, filing and finance\nDeveloping target product profiles for priority pathogens\nHow to mobilize private investors for antibiotic drug development\nWellcome Trust: funding opportunities for anti-infective research\nConsiderations for beta-lactams paired with beta-lactamase inhibitors\nA unique combination antibiotic therapy at Helperby\nRidinilazole for the treatment of C. difficile\nDeveloping new therapies for fungal infection\nPharmacodynamics to accelerate antimicrobial drug development for AMR\nOpportunities and challenges involved in pre-clinical development of novel immunotherapies\nEvaluations in prophylaxis and treatment murine models of pneumocystis pneumonia\n\nTo register visit www.superbugssuperdrugs.com/globalbiodefence \nGlobal Biodefense in an official media partner of Superbugs & Superdrugs 2019.
URL:https://globalbiodefense.com/event/superbugs-superdrugs-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Rd\, London\, SW7 4DN\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/11/superbugs-2019-london.jpg
END:VEVENT
END:VCALENDAR